Evidence map›Paper›PMID 41105783›Full record

ArticleScience advances2025

Lyn restrains lupus via kinase-independent mechanisms that limit Toll-like receptor activation and type I interferon responsiveness.

Elan L'Estrange-Stranieri, Timothy A Gottschalk, Anne M Kong, Mhairi J Maxwell, Ee Shan Pang, Evelyn Tsantikos, David M Tarlinton, Meredith O'Keeffe, Mark D Wright, Margaret L Hibbs

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elan L'Estrange-StranieriDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0001-8909-0994
Timothy A GottschalkDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0002-7953-5555
Anne M KongDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.
Mhairi J MaxwellDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0001-5530-4982
Ee Shan PangDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0003-4325-6260
Evelyn TsantikosDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0002-3841-3674
David M TarlintonDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0001-9928-686X
Meredith O'KeeffeDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0002-0779-4654
Mark D WrightDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0002-2177-5214
Margaret L HibbsDepartment of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0002-3751-6751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lyn phosphorylates inhibitory immunoreceptors to terminate signaling; consequently, Lyn deficiency in mice causes hyperactive immune cells and lupus-like autoimmune disease. Lyn may also suppress autoimmunity independent of its kinase activity through inhibitory protein-protein binding interactions, although the importance of this mechanism is unclear. To analyze the kinase-independent functions of Lyn, mice expressing a catalytically inactive mutant of Lyn were generated and their phenotype compared to Lyn-deficient mice. Disease progression was blunted in Lyn kinase-dead mice indicating a contribution for kinase-independent Lyn functions in restraining autoantibody production, glomerulonephritis, Toll-like receptor signaling, and splenomegaly. Further comparative analyses identified an exclusive role for the kinase-dependent functions of Lyn in regulating B cell receptor signaling, dendritic cell phenotype, and type I interferon production. By contrast, interferon-stimulated gene expression and the regulation of thymic epithelial cell development and T cell selection are previously unidentified, exclusively kinase-independent functions for Lyn. Collectively, these findings further our understanding of the nuanced roles of Lyn in health and disease.

Indexed as

Interferon Type ILupus Erythematosus, Systemicsrc-Family KinasesToll-Like ReceptorsAnimalsDendritic CellsDisease Models, AnimalMiceMice, KnockoutSignal TransductionInterferon Type Ilyn protein-tyrosine kinasesrc-Family KinasesToll-Like Receptors

Identifiers

PMID41105783
PMCPMC12533645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.